Wegovy, Zepbound makers’ stocks rally as a weight-loss-drug competitor
drops out
-
Pfizer’s announcement that it will stop developing its oral weight-loss
drug gave shares of Wegovy maker Novo Nordisk and Zepbound maker Eli Lilly
a lift.
10 minutes ago
No comments:
Post a Comment